Skip to main content
Premium Trial:

Request an Annual Quote

Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System

NEW YORK — Personal Genome Diagnostics said on Tuesday that it has signed an agreement to provide its Elio Tissue Complete next-generation sequencing test platform to the Duke University Health System Clinical Molecular Diagnostics Laboratory.

Elio Tissue Complete is a US Food and Drug Administration-cleared 507-gene panel kit that identifies single-nucleotide variants, small insertions and deletions, amplifications, rearrangements, microsatellite instability, and tumor molecular burden in DNA from patient tissue samples.

According to Personal Genome Diagnostics, or PGDx, the platform will be integrated into the Duke lab and be used as its primary technology for clinical oncology genomic testing initiatives. As part of the deal, the Baltimore-based company and DUHS will collaborate on a data integration system to join the health system's electronic health records with other local systems.

Financial and other terms of the collaboration were not disclosed.

"We believe strongly that the ability to provide accurate, rapid genomic profiling data and insights that can be easily accessed and incorporated into existing cancer care pathways will allow our clinicians to further optimize treatments for the benefit of our patients," Michael Datto, associate VP of DUHS Clinical Laboratories, said in a statement.

Earlier this year, PGDx raised $103 million in Series C funding that it has been using to expand its commercial infrastructure and forge new agreements with diagnostic and pharmaceutical partners.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.